|
Becton Dickinson
anti-human crth2 pe-cf594 bm16 ![]() Anti Human Crth2 Pe Cf594 Bm16, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/crth2++bm16+antibody/pmc10213874-40-0-6 Average 90 stars, based on 1 article reviews
anti-human crth2 pe-cf594 bm16 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
anti human crth2pe ![]() Anti Human Crth2pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/CD294+(CRTH2)+Antibody%2C+anti-human%2C+REAfinity/pm37680638-64-27-33 Average 93 stars, based on 1 article reviews
anti human crth2pe - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd294 (crth2) antibody, anti-human ![]() Cd294 (Crth2) Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/CD294+(CRTH2)+Antibody%2C+anti-human/custom%40130-114-126%4034973310 Average 92 stars, based on 1 article reviews
cd294 (crth2) antibody, anti-human - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
ProSci Incorporated
anti crth2 antibody ![]() Anti Crth2 Antibody, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/CRTH2+Antibody/pmc05736881-36-31-33 Average 92 stars, based on 1 article reviews
anti crth2 antibody - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
fluidigm
3163003b ![]() 3163003b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/Anti-Human+CD294%2FCRTH2+(BM16)-163Dy/pmc09255966-23-11-8 Average 93 stars, based on 1 article reviews
3163003b - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
biotin anti crth2 rea598 ![]() Biotin Anti Crth2 Rea598, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/Biotin+Antibody/pm29023707-4187-85-88 Average 96 stars, based on 1 article reviews
biotin anti crth2 rea598 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Charles River Laboratories
monoclonal antibody against human crth2 ![]() Monoclonal Antibody Against Human Crth2, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/monoclonal+antibody+against+human+crth2/us10100120-578-2-27 Average 90 stars, based on 1 article reviews
monoclonal antibody against human crth2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
ProSci Incorporated
crth2 ![]() Crth2, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/PTGDR2+Peptide/pmc03511345-64-7-29 Average 93 stars, based on 1 article reviews
crth2 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
αcrth2 antibody coated microbeads ![]() αcrth2 Antibody Coated Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/CD294+(CRTH2)+MicroBead+Kit%2C+human/pmc04693727-68-3-9 Average 93 stars, based on 1 article reviews
αcrth2 antibody coated microbeads - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Bioss
rabbit anti human crth2 polyclonal antibody ![]() Rabbit Anti Human Crth2 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/GPR44+Polyclonal+Antibody/pm40445384-105-3-9 Average 94 stars, based on 1 article reviews
rabbit anti human crth2 polyclonal antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Novus Biologicals
crth2 dp2 ![]() Crth2 Dp2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/DP2+Antibody/pmc05855778-132-37-38 Average 86 stars, based on 1 article reviews
crth2 dp2 - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
GeneTex
rabbit anti-human crth2 polyclonal antibody ![]() Rabbit Anti Human Crth2 Polyclonal Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+human+crth2+receptor+antibody/rabbit+anti+human+crth2+polyclonal+antibody/pm18802357-36-6-20 Average 90 stars, based on 1 article reviews
rabbit anti-human crth2 polyclonal antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell Reports Medicine
Article Title: The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis
doi: 10.1016/j.xcrm.2023.101038
Figure Lengend Snippet:
Article Snippet:
Techniques: Software, Staining
Journal: eLife
Article Title: Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV
doi: 10.7554/eLife.78870
Figure Lengend Snippet:
Article Snippet: Antibody , Anti-Human CD294/CRTH2 (BM16) (Rat, Monoclonal) ,
Techniques: Recombinant, Plasmid Preparation, Software
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: The primer sequences used for amplification of CRTH2.
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: Amplification
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: The incubation conditions and the catalogue numbers for all antibodies used.
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: Incubation
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: mRNA was isolated from cultured amniocytes, myocytes, PBMCs, choriodecidual and placental extracts and converted to cDNA (n = 6). Qualitative PCR was used with three primer sets to amplify CRTH2 showing product sizes of 309 bp, 265 bp, and 114 bp. Non-template and reverse transcriptase negative controls were used and mRNA from placenta, choriodecidua and peripheral blood mononuclear cells were used as a positive controls. ( A , B ): Non-template control (lane 1), amniocytes (lane 2), choriodecidua (lane 3), myocytes (lane 4), placenta (lane 5); ( C ): Reverse transcriptase controls (lanes 1,3,5,7,9), PBMCs (lane 2), amniocytes (lanes 4,6), myocytes (lanes 8,10).
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: Isolation, Cell Culture, Reverse Transcription, Control
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: 50 µg of whole cell lysate from PBMCs, amniocytes, myocytes were subject to western analysis. Membranes were probed with the primary antibody -SC-23092 to detect a Mr∼34 000 product ( A ; Lanes 1–3). The secondary antibody control blot is also shown ( B ; Lanes 1–3). β-actin was used as a loading control. Lane 1 = PBMCs, lane 2 = amniocytes, lane 3 = myocytes. Multiple bands are seen on the blot. A band appears at Mr∼34 000 in amniocytes, faintly in the myocyte lane, but is absent in the positive control PBMCs lane. However, the strongest bands appear at Mr∼15 000 and at just above Mr∼43 000 in all lanes. Myocytes from passage zero, one, two, three and four (lanes 1–5 respectively) were also examined for CRTH2 expression showing a very faint band at Mr∼34 000, with no effect of passage number ( C ).
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: Western Blot, Control, Positive Control, Expressing
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: The in vitro transcription translation kit was used with 35 S Methionine to demonstrate the expression of CRTH2 and to provide a positive control for detection of CRTH2. A Mr∼34 000 product was detected by x-ray (Lane 2). The progesterone expression vector was used as a control for the TNT kit ( A ). The protein lysate from the TNT kit was subjected to western analysis; Negative Control: TNT kit with no plasmid DNA (lane 1), Negative control: Progesterone PSG5 Expression vector (lane 2), Positive control: 35 S Methionine labelled CRTH2 (Lane 3), Cold Methionine CRTH2 protein product (lane 4). Membranes were probed with 3 commercial antibodies; SC-23092 ( B ), SC-21798 ( C ), ProSci 4027 ( D ). None of the antibodies detected CRTH2.
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: In Vitro, Expressing, Positive Control, Plasmid Preparation, Control, Western Blot, Negative Control
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: Lymphocytes were gated according to forward scatter and side scatter and T helper cells were identified using CD4 as a cell surface marker (n = 6). A representative cytogram is presented with the right upper quadrant showing CRTH2 + /CD4 + lymphocytes ( A ). Histograms showing no staining, isotype control and CRTH2 + labelled lymphocytes ( B ), amniocytes ( C ) and myocytes ( D ), (n = 5).
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: Marker, Staining, Control
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: An overview of the mean fluorescence intensities and percentages in the gated cells during detection of endogenous CRTH2 in lymphocytes, amniocytes and myocytes.
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: Fluorescence
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: Amniocytes ( A ) and myocytes ( B ) were transfected using gene juice and electroporation respectively with CRTH2 PSG5 expression vector and labeled with anti-CRTH2-PE. A small shift to the right is seen in the histogram showing expression of CRTH2 in transfected cells with an increase in the mean fluorescence intensity from 87.75 in the isotype control to 143.49 in amniocytes, and from 68.84 to 96.97 in myocytes. An example of a GFP control is given for the myocyte transfection, with cells imaged with phase contrast and with the fluorescent microscope to detect GFP transfected cells ( C ). A direct comparison is also shown with non-GFP transfected cells ( D ).
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: Transfection, Electroporation, Expressing, Plasmid Preparation, Labeling, Fluorescence, Control, Microscopy, Comparison
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: An overview of the mean fluorescence intensities and percentages in the gated cells during detection of transfected CRTH2 in amniocytes and myocytes.
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: Fluorescence, Transfection
Journal: PLoS ONE
Article Title: Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes
doi: 10.1371/journal.pone.0050734
Figure Lengend Snippet: PBMCs were treated with 32 µM of 15dPGJ2 for 2 hours with or without preincubation with 2 µM of GSKCRTH2X for 45 mins. Whole cell protein lysate was examined for levels of phosphorylated p65 (p-p65) using immunoblotting. A representative immunoblot from n = 6 samples are shown ( A ). Immunoblots were reprobed for β-actin as an internal loading control. Densitometric analysis of the immunoblots was conducted revealing a complete inhibition of p-p65 levels with 15dPGJ2. Pre-incubation with the CRTH2 antagonist GSKCRTH2X had no effect on inhibition ( B ). J2 = 15dPGJ2, GSKX = GSKCRTH2X. Effect of treatment was examined for statistical significance using ANOVA of repeated measures with Bonferroni’s multiple comparison test; **** P <0.0001.
Article Snippet: Antibodies against phospho-p65 (Ser 536), p65 and
Techniques: Western Blot, Control, Inhibition, Incubation, Comparison
Journal: Immunity, Inflammation and Disease
Article Title: Interleukin‐25 initiates Th2 differentiation of human CD4 + T cells and influences expression of its own receptor
doi: 10.1002/iid3.87
Figure Lengend Snippet: IL‐25R is highly expressed by in vitro differentiated CRTh2 + Th2 cells. Flow cytometry of (A) surface CRTh2 (solid line) compared with isotype control (dotted line; day 42) and (B) intra‐cellular IL‐4, IL‐13 and IFN‐γ⋅ (C) qRT‐PCR for IL‐25R mRNA from activated CRTh2 + Th2 cells (day 45, black bar, n = 6 independently differentiated lines) were compared with activated non‐polarized CD4 + T cells (day 3, white bar, 61‐fold, n = 5). (D) Representative example of surface IL‐25R expression (solid line) compared to isotype control (dotted line) by differentiated CRTh2 + Th2 cells (day 43) and (E) kinetics of surface IL‐25R expression following TCR activation ( n = 4, three independently differentiated lines). Statistical significance was determined by Student's t test, * P < 0.05.
Article Snippet: On day 14,
Techniques: In Vitro, Flow Cytometry, Control, Quantitative RT-PCR, Expressing, Activation Assay
Journal: Immunity, Inflammation and Disease
Article Title: Interleukin‐25 initiates Th2 differentiation of human CD4 + T cells and influences expression of its own receptor
doi: 10.1002/iid3.87
Figure Lengend Snippet: IL‐25 mediates acquisition of the Th2 phenotype. Naïve CD4 + T cells were differentiated in non‐polarizing (NP) control conditions (αCD3/αCD28, IL‐2, αIFNγ and αIL‐12) or NP + IL‐4 (IL‐4), NP + IL‐25 (IL‐25) or NP + IL‐4 and IL‐25 (IL‐4+IL‐25). (A) IL‐25R mRNA expression (fold increase over NP; day 3, 7, 10, 14, n = 10 of three independently differentiated lines). (B) Intracellular IL‐4 and (E) surface CRTh2 were assayed following proliferation (day 7, 14, n = 17, 10 independently differentiated lines). (D) GATA3 was assayed after stimulation (day 3, 10, n = 17, 10 independently differentiated lines). (C) IL‐4 mRNA expression by cells cultured in IL‐4 or IL‐25 (fold increase over NP, day 14; n = 4 independently differentiated lines). (F) Cell counts were determined and comparison was made between the four conditions for each day. Statistical significance determined by repeated measures ANOVA, * P < 0.05.
Article Snippet: On day 14,
Techniques: Control, Expressing, Cell Culture, Comparison
Journal: Immunity, Inflammation and Disease
Article Title: Interleukin‐25 initiates Th2 differentiation of human CD4 + T cells and influences expression of its own receptor
doi: 10.1002/iid3.87
Figure Lengend Snippet: Regulation of IL‐25R on Th2 cells. Differentiated CRTh2 + Th2 cells were cultured with IL‐2 in the presence or absence of IL‐25 and stained for (A) IL‐25R ( n = 5, three independently differentiated cell lines) or assessed for (B) IL‐25R mRNA levels ( n = 3). (C) Surface expression of IL‐25R on CRTh2 + Th2 cells treated (24 h) with a CRTh2 agonist (DK‐PGD 2 ) or IL‐2 ( n = 4). Statistical significance determined by paired t test within each time point (A, B) or between conditions (C), * P < 0.05.
Article Snippet: On day 14,
Techniques: Cell Culture, Staining, Expressing
Journal: Immunity, Inflammation and Disease
Article Title: Interleukin‐25 initiates Th2 differentiation of human CD4 + T cells and influences expression of its own receptor
doi: 10.1002/iid3.87
Figure Lengend Snippet: IL‐25 slows re‐expression of CRTh2 on Th2 cells following TCR activation. (A) Differentiated CRTh2 + Th2 cells cultured with IL‐2, αCD3 and αCD28 exhibited time dependent loss of surface CRTh2 expression ( n = 4, two independently differentiated cell lines). (B–G) CRTh2 + Th2 cells were cultured with IL‐2, αCD3 and αCD28 (24 h) and then placed with IL‐2 in the presence or absence of IL‐25 (another 24 h). % of cells expressing (B) CRTh2, (D) CD62L or (F) CCR4 and mean fluorescent intensity (MFI) for (C) CRTh2, (E) CD62L and (G) CCR4 were quantified ( n = 6, two independently differentiated lines). Statistical significance was determined by paired t test (B–G), * P < 0.05.
Article Snippet: On day 14,
Techniques: Expressing, Activation Assay, Cell Culture